1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA GMFG CTRPv2 pan-cancer AAC 0.31 4e-10
mRNA WAS CTRPv2 pan-cancer AAC 0.3 3e-06
mRNA PARVG CTRPv2 pan-cancer AAC 0.27 2e-12
mRNA CECR6 CTRPv2 pan-cancer AAC 0.27 6e-15
mRNA PTPN7 CTRPv2 pan-cancer AAC 0.26 8e-08
mRNA ARHGAP45 CTRPv2 pan-cancer AAC 0.26 2e-07
mRNA ELAVL3 CTRPv2 pan-cancer AAC 0.26 3e-09
mRNA RASGRP2 CTRPv2 pan-cancer AAC 0.26 1e-09
mRNA NCKAP1L CTRPv2 pan-cancer AAC 0.25 5e-07
mRNA KIAA0408 CTRPv2 pan-cancer AAC 0.25 1e-09
Download CSV